Extensively validated models spinning 40+ disease states to get you the pharmacological answers your study needs.
Staff Average Years Experience
FDA Part 11 Compliant
FDA / CFDA IND fillings
AAALAC / CNAS Compliant Studies
Providing Better Data for Critical Immuno-Oncology Pipeline Decisions
PharmaLegacy works to get you the answers you need with our wide selection of carefully developed in vivo and in vitro models. In this document, you’ll see a sample of the in vitro assays we run along with a sample of real-world data from them. See why over 700 pharmaceutical companies, including many global leaders, trust PharmaLegacy for the unbiased, accurate information they need to make critical pipeline decisions.